薬物依存症治療市場：タイプ別、治療法別、投与経路別、エンドユーザー別、地域別

世界の薬物依存症治療市場は、2024年には176億1,000万米ドルと推定され、2031年には287億2,000万米ドルに達すると予測され、2024年から2031年までのCAGRは7.2%です。

図.薬物依存症治療市場シェア（%）、2024年地域別

世界の薬物依存症治療市場は、先進国・新興国を問わず薬物乱用の蔓延が進んでいることから、近年の動向は堅調です。国連薬物犯罪事務所（UNODC）によると、2020年6月、世界で約2億6,900万人が少なくとも一度は薬物を使用したことがあります。社会経済的な脆弱性と相まって、違法薬物が容易に入手できるようになったことが、薬物依存の危機に大きく寄与しています。これに対して各国政府は、薬物使用障害の克服を支援するため、エビデンスに基づく治療サービスを提供する取り組みを強化しています。このことが、世界の薬物依存症治療市場における様々な薬理学的・心理学的な依存症治療薬や治療法の需要を大きく押し上げています。

市場力学：

世界の薬物依存症治療市場の成長を促進する主な要因には、薬物乱用障害を犯罪化する代わりに治療を必要とする病状として社会的に受け入れられていること、治療施設を拡大するための政府によるヘルスケア支出の増加、オピオイド危機の一因となるオピオイド鎮痛薬使用者の増加などがあります。しかし、解毒後の社会的支援プログラムの欠如、薬物乱用治療にまつわる偏見、専門的な依存症治療訓練を受けた医療従事者の不足といった要因が、市場関係者に課題を突きつけています。プラス面では、より優れた安全性と有効性プロファイルを持つ新規治療薬の研究が進行中であることや、カウンセリングプログラムにおけるデジタル技術の統合が、利害関係者に高い成長機会をもたらしています。

本調査の主な特徴

本レポートでは、世界の薬物依存症治療市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模と年間平均成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界の薬物依存症治療市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主要企業には、Indivior PLC、Pfizer Inc.、Johnson &Johnson、Alkermes、Mallinckrodt Pharmaceuticals、Teva Pharmaceutical Industries、GSK Plc.、AbbVie Inc.、Otsuka Pharmaceutical Co., Ltd.、Lundbeck A/S、Hikma Pharmaceuticals、Alkermes Plc.、Sandoz（a Novartis division）、AcelRx Pharmaceuticals、Nuvectra Corporationなどがあります。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の薬物依存症治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の薬物依存症治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の薬物依存症治療市場、タイプ別、2019～2031年

• オピオイド中毒
• ベンゾジアゼピン中毒
• バルビツール酸中毒
• その他

第5章 世界の薬物依存症治療市場、治療法別、2019～2031年

• セラピー
• 薬物療法
• その他

第6章 世界の薬物依存症治療市場、投与経路別、2019～2031年

• 経口
• 非経口
• その他

第7章 世界の薬物依存症治療市場、エンドユーザー別、2019～2031年

• 病院
• 専門クリニック
• リハビリテーションセンター
• その他

第8章 世界の薬物依存症治療市場、地域別、2019～2031年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Indivior PLC
• Pfizer Inc.
• Johnson & Johnson
• Alkermes
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceutical Industries
• GSK Plc.
• AbbVie Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Lundbeck A/S
• Hikma Pharmaceuticals
• Alkermes Plc.
• Sandoz（a Novartis division）
• AcelRx Pharmaceuticals
• Nuvectra Corporation

第10章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

The global drug addiction treatment market is estimated to be valued at USD 17.61 Bn in 2024 and is expected to reach USD 28.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Figure. Drug Addiction Treatment Market Share (%), By Region 2024

The global drug addiction treatment market has been witnessing steady growth in the recent past owing to the rising prevalence of drug abuse across both developed and developing nations worldwide. In June 2020, according to the United Nations Office on Drugs and Crime (UNODC), around 269 million people worldwide used drugs at least once in 2020. The easy availability of illicit substances coupled with socio-economic vulnerabilities has significantly contributed to the drug addiction crisis. In response, governments across countries have been ramping up efforts to provide evidence-based treatment services to help individuals overcome substance use disorders. This has majorly driven the demand for various pharmacological and psychological addiction treatment drugs and therapies in the global drug addiction treatment market.

Market Dynamics:

The key drivers propelling the global drug addiction treatment market growth include growing social acceptance of drug abuse disorders as a medical condition requiring treatment instead of criminalization, increasing healthcare spending by governments to expand treatment facilities, and rising number of opioid analgesic users contributing to the opioid crisis. However, factors such as lack of social support programs post-detoxification, stigma associated with substance abuse treatment, and scarcity of medical professionals with specialized addiction treatment training pose challenges to market players. On the positive side, ongoing research for novel treatment drugs with better safety and efficacy profiles as well as integration of digital technologies in counseling programs present high-growth opportunities for stakeholders.

Key Features of the Study:

This report provides an in-depth analysis of the global drug addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Indivior PLC, Pfizer Inc., Johnson & Johnson, Alkermes, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, GSK Plc., AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Lundbeck A/S, Hikma Pharmaceuticals, Alkermes Plc., Sandoz (a Novartis division), AcelRx Pharmaceuticals, and Nuvectra Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug addiction treatment market

Market Segmentation

• By Types Insights (Revenue, USD Bn, 2019 - 2031)
  • Opioid Addiction
  • Benzodiazepine Addiction
  • Barbiturate Addiction
  • Others
• By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
  • Therapy
  • Medication
  • Others
• By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Oral
  • Parenteral
  • Others
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Specialty Clinics
  • Rehabilitation Center
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Indivior PLC
  • Pfizer Inc.
  • Johnson & Johnson
  • Alkermes
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceutical Industries
  • GSK Plc.
  • AbbVie Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Lundbeck A/S
  • Hikma Pharmaceuticals
  • Alkermes Plc.
  • Sandoz (a Novartis division)
  • AcelRx Pharmaceuticals
  • Nuvectra Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Addiction Treatment Market, By Types
  • Global Drug Addiction Treatment Market, By Treatment
  • Global Drug Addiction Treatment Market, By Route of Administration
  • Global Drug Addiction Treatment Market, By End User
  • Global Drug Addiction Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Drug Addiction Treatment Market, By Types, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Opioid Addiction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Benzodiazepine Addiction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Barbiturate Addiction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Addiction Treatment Market, By Treatment, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Addiction Treatment Market, By Route of Administration, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Addiction Treatment Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Rehabilitation Center
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Drug Addiction Treatment Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Indivior PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alkermes
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceutical Industries
• GSK Plc.
• AbbVie Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Lundbeck A/S
• Hikma Pharmaceuticals
• Alkermes Plc.
• Sandoz (a Novartis division)
• AcelRx Pharmaceuticals
• Nuvectra Corporation

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us